Ufp Technologies (UFPT) Cash & Current Investments (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Cash & Current Investments came in at $20.0 million in Q1 2026, up 42.4% YoY from $14.0 million in Q1 2025, and down 1.6% on a QoQ basis from $20.3 million in Q4 2025.
Ufp Technologies (UFPT) Cash & Current Investments (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 17 years of Cash & Current Investments data on file, last reported at $20.0 million in Q1 2026.
- Quarterly Cash & Current Investments rose 42.4% year-over-year to $20.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.0 million (up 42.4% YoY) and the FY2025 annual result came in at $20.3 million, up 50.94% from the prior year.
- Cash & Current Investments retreated to $20.0 million in Q1 2026, from $20.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $20.3 million in Q4 2025 to a low of $3.7 million in Q1 2022.
- A 5-year average of $11.7 million and a median of $12.4 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments sank 85.61% — and 2024, when it soared 216.16%.
- Tracing UFPT's Cash & Current Investments over 5 years: stood at $4.5 million in 2022, then soared by 43.25% to $6.4 million in 2023, then jumped by 110.95% to $13.4 million in 2024, then jumped by 50.94% to $20.3 million in 2025, then dropped by 1.6% to $20.0 million in 2026.
- The last three Cash & Current Investments figures came in at $20.0 million (Q1 2026), $20.3 million (Q4 2025), and $18.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Ufp Technologies | 2.39 Bn | 2.38 Bn | 50.92 Mn | 9.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.05 Mn |
| Mar 31, 2026 | 19.98 Mn |
| Dec 31, 2025 | 20.30 Mn |
| Sep 30, 2025 | 18.23 Mn |
| Jun 30, 2025 | 14.89 Mn |
| Mar 31, 2025 | 14.03 Mn |
| Dec 31, 2024 | 13.45 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 16.73 Mn |
| Mar 31, 2024 | 11.37 Mn |
| Sep 30, 2023 | 6.38 Mn |
| Jun 30, 2023 | 5.29 Mn |
| Mar 31, 2023 | 6.50 Mn |
| Dec 31, 2022 | 4.45 Mn |
| Sep 30, 2022 | 9.94 Mn |
| Jun 30, 2022 | 5.58 Mn |
| Mar 31, 2022 | 3.65 Mn |
| Sep 30, 2021 | 33.09 Mn |
| Jun 30, 2021 | 30.27 Mn |
| Mar 31, 2021 | 25.38 Mn |